Ignite Creation Date:
2024-05-05 @ 11:25 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01329276
Status:
COMPLETED
Last Update Posted:
2011-04-05
First Post:
2011-03-30
Brief Title:
Assess Particle Deposition and Acute Effects of Symbicort Forte Turbohaler in COPD Patients
Sponsor:
University Hospital Antwerp
Organization:
University Hospital Antwerp
Study Overview
Official Title:
A Randomized Double-blind Placebo-controlled Two Way Cross-over Study to Assess the Particle Deposition and Acute Effects of Formoterol and Budesonide Combination Therapy Symbicort Forte Turbohaler on the Upper Airway Dimensions in COPD Patients
Status:
COMPLETED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Computational Fluid Dynamics CFD is a new functional imaging method Since CFD is very sensitive to detect small changes it might be worthwhile to study the acute effect of formoterol and budesonide combination therapy Symbicort forte Turbohaler on the upper airway dimensions in severe COPD patients GOLD III The increased sensitivity of this technique makes it possible to detect changes in airway caliber in early stages The regional distribution of resistance and the change in this parameter will provide more insight into the mode of action of the product
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2009-016502-16 | EUDRACT_NUMBER | None | None |